Key Developments For Anika Therapeutics Inc
Anika Therapeutics Inc (ANIK.O) (Nasdaq)
Anika Therapeutics, Inc. Receives European CE Mark Approval For 'ELEVESS Light'
Anika Therapeutics, Inc. announced that it has received European CE Mark approval for 'ELEVESS Light,' the Company's latest aesthetic product used for the treatment of fine lines and facial wrinkles. ELEVESS Light will be distributed in the European market by the Company's current aesthetic dermatology distributors.
Anika Therapeutics, Inc. Reaffirms FY 2009 Guidance
Anika Therapeutics, Inc. announced that it is confident that the Company will deliver good revenue growth and improved profitability for fiscal 2009. According to Reuters Estimates, analysts were expecting the Company to report revenues of $40.10 million and EPS of $0.34 for the same period.
Anika Therapeutics, Inc. Receives Health Canada Approval For MONOVISC
Anika Therapeutics, Inc. announced that it has received Health Canada approval for MONOVISC, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp.
Anika Therapeutics, Inc. Reaffirms FY 2009 Guidance
Anika Therapeutics, Inc. announced that it continue to expect to generate good revenue growth and improved profitability in fiscal 2009. According to Reuters Estimates, analysts were expecting the Company to report revenues of $40.56 million and EPS of $0.34 for the same period.
Anika Therapeutics, Inc. Announces U.S. Distribution Agreement With Facial Aesthetics Provider Coapt Systems for Aesthetic Dermatology Franchise
Anika Therapeutics, Inc. announced that it has signed an exclusive U.S. distribution agreement with Palo Alto, California based Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems` suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anika`s HA-based injectable filler that corrects lines and wrinkles on the face. Under the terms of the agreement, Coapt Systems will distribute Anika`s aesthetic dermatology product exclusively in the United States for five years and there are two additional renewable terms. Developing line extensions for the aesthetic dermatology franchise will be a priority as Anika and Coapt Systems fill out the family of products.
